Wednesday, August 10, 2022
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Infectious Emerging Diseases

Hydrogen sulfide critical to innate ability of bacteria to survive antibiotics

June 10, 2021
in Infectious Emerging Diseases
0
Share on FacebookShare on Twitter

Prototype drugs found to strengthen antibiotics by blocking bacterial H2S biogenesis

The signaling molecule hydrogen sulfide (H2S) plays a critical role in antibiotic tolerance, the innate ability of bacteria to survive normally lethal levels of antibiotics, a new study finds.

Published online in the journal Science on June 11, the study revolves around tolerance, wherein bacteria in general have evolved to use common defense systems to resist antibiotics. Tolerance differs from antibiotic resistance, where one species happens to acquire a genetic change that helps them resist treatment.

In one defense mechanism, tolerant bacteria, also called “persisters,” stop multiplying (proliferating), reducing their energy use (metabolism) to survive antibiotic treatment, but resuming growth when the treatment ends. Persisters are particularly abundant in biofilms, bacterial colonies that live in tough polymeric matrices which further prevent their eradication.

“The combined trends toward resistant infections and fewer new antimicrobials are projected to kill 10 million people annually by the year 2050,” says corresponding study author Evgeny Nudler, PhD, the Julie Wilson Anderson Professor of Biochemistry at NYU Langone Health, and an investigator with the Howard Hughes Medical Institute. “New approaches are urgently needed to prevent this, and our study suggests that suppressing bacterial H2S would make different antibiotics more potent.”

In their prior work, the NYU Langone research team showed that H2S production is deployed against antibiotics by a wide variety of bacterial species, including two increasingly antibiotic-resistant pathogens prevalent in hospital-borne infections: Staphylococcus aureus and Pseudomonas aeruginosa. S. aureus is gram-positive, while Pseudomonas aeruginosa is gram-negative, with the differing organizations of their outer layers demonstrating that H2S production protects pathogens across the bacterial kingdom.

Remarkably, the research team team found that both species rely on the same enzyme, cystathionine γ-lyase (CSE), for the bulk of H2S production. Blocking its action would represent then a way to remove an important defense against antibiotics, but available CSE inhibitors have a low potency against bacterial CSE and a high probability of causing side effects in human tissue, says Nudler.

To find better inhibitors, the research team obtained an x-ray structure of S. aureus CSE and used it to “virtually screen” millions of drug-like compounds looking for those with the right shape and properties to block the enzyme’s action without side effects. The team selected lead compounds, NL1, NL2, and NL3, which inhibited the bacterial CSE, blocked H2S production by both S. aureus and P. aeruginosa, and strengthened the effect of bactericidal antibiotics from different classes. Furthermore, NL1 increased the potency of antibiotic effect in mouse models of S. aureus and P. aeruginosa infection.

Unexpectedly, further testing revealed that the NL compounds markedly diminished persisters, and suppressed biofilm formation in both pathogens. How exactly H2S contributes to tolerance remains to be established, but there are some hints.

“Bacteria appear to use controlled, self-poisoning with H2S to slow down their metabolism, preventing the antibiotics from using the bacteria’s energy production system to kill them,” says Nudler. “Interfering with the H2S-based defenses represents a largely unexplored alternative to the traditional antibiotic discovery. Our results suggest that a new kind of small molecule potentiator can strengthen the effect of major classes of clinically important antibiotics.”

The authors note several opportunities for designing conceptually novel antimicrobial therapeutics by combining H2S-blocking potentiators with antibiotics. Such combinations may have better efficacy against bacterial biofilms. Other potential applications include overcoming intermediate-level antibiotic resistance; reducing antibiotic dose and related toxicity while maintaining efficacy; and enhancing the bacteria-killing (bactericidal) effect at the same antibiotic dose.

###

Along with Nudler, the study was led by first authors Konstantin Shatalin and Ashok Nuthanakanti in the Department of Biochemistry and Molecular Pharmacology at NYU Langone Health. Also authors were Abhishek Kaushik, Alla Peselis, Ilya Shamovsky, Bibhusita Pani, Mirna Lechpammer, Nikita Vasiliev, Elena Shatalina, and Alexander Serganov at NYU Langone, as well as Dmitry Shishov and Peter Fedichev of Gero LLC, Moscow, Russia; Dmitri Rebatchouk of Ellyris LLC in Union, NJ; and Alexander Mironov of the Engelhardt Institute of Molecular Biology, Russian Academy of Sciences in Moscow. The study was funded by the Blavatnik Family Foundation, the United States Department of Defense, and the Howard Hughes Medical Institute.

Media Contact
Greg Williams
[email protected]
http://dx.doi.org/10.1126/science.abd8377

Tags: BacteriologyInfectious/Emerging DiseasesMedicine/HealthMicrobiology
Share25Tweet16Share4ShareSendShare
  • A role for cell ‘antennae’ in managing dopamine signals in the brain

    99 shares
    Share 40 Tweet 25
  • Order up: new study reveals importance of liquid structural ordering in crystallization

    79 shares
    Share 32 Tweet 20
  • Study finds second primary lung cancer is 4 percent and as high as 8 percent among surgery patients

    78 shares
    Share 31 Tweet 20
  • United Kingdom-based smoking cessation program reports that 30 percent of support in a lung cancer screening program: the Yorkshire Enhanced Stop Smoking Study (YESS)

    77 shares
    Share 31 Tweet 19
  • NELSON trial protocol more sensitive than NLST and may increase the benefits of lung cancer screening, while reducing unnecessary follow-up procedures

    77 shares
    Share 31 Tweet 19
  • Sub-lobar surgery for peripheral non-small cell lung cancer non-inferior to lobectomy

    76 shares
    Share 30 Tweet 19
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

A role for cell ‘antennae’ in managing dopamine signals in the brain

Experts optimistic about converting coal plants to production of clean geothermal energy

The walk of Japanese children develops differently from children in other countries

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 193 other subscribers

© 2022 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2022 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In